N-[3-BROMO-2-CHLORO-4-(4, 5-DIHYDRO-1H-IMIDAZOL-2-YLMETHYL)-PHENYL] -METHANESULFOAMIDE AS ALPHA-1 A ADRENERGIC PARTIAL AGONIST FOR THE TREATMENT OF INCONTINENCE

This invention relates to an alpha-1 A receptor partial agonist, which is represented by Formula I: and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing formula I, methods for their use as therapeutic agents, and methods o...

Full description

Saved in:
Bibliographic Details
Main Authors O'YANG, COUNDE, YASUDA, DENNIS MITSUGU
Format Patent
LanguageEnglish
French
Published 13.08.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This invention relates to an alpha-1 A receptor partial agonist, which is represented by Formula I: and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing formula I, methods for their use as therapeutic agents, and methods of preparation thereof. La présente invention concerne un agoniste partiel des récepteurs alpha-1 A, qui est représenté par la formule (I), et des sels ou solvates pharmaceutiquement acceptables de celui-ci. L'invention concerne en outre des compositions pharmaceutiques contenant la formule (I), des procédés de leur utilisation en tant qu'agents thérapeutiques et leurs procédés de préparation.
Bibliography:Application Number: WO2009EP50838